We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+4.04%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$16.9B
AUM Growth
+$588M
Cap. Flow
+$89.1M
Cap. Flow %
0.53%
Top 10 Hldgs %
18.71%
Holding
742
New
20
Increased
188
Reduced
506
Closed
5

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$52.6M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$35.1M
3
V icon
Visa
V
+$32.9M
4
LVS icon
Las Vegas Sands
LVS
+$31.4M
5
AMAT icon
Applied Materials
AMAT
+$26M

Top Sells

Rank Stock Value
1
GLIN icon
VanEck India Growth Leaders ETF
GLIN
+$57.5M
2
MO icon
Altria Group
MO
+$42.9M
3
TWX
Time Warner Inc
TWX
+$37.4M
4
MMM icon
3M
MMM
+$33.3M
5
MON
Monsanto Co
MON
+$26.8M

Sector Composition

Rank Sector Weight
1 Technology 17.74%
2 Financials 16.91%
3 Healthcare 13.21%
4 Consumer Discretionary 10.2%
5 Communication Services 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENB icon
126
Enbridge
ENB
$121B
$30.6M 0.18%
859,591
+17,119
+2% +$542K
SCHW
127
Charles Schwab
SCHW
$181B
$30.6M 0.18%
599,284
-1,890
-0.3% -$105K
CNI icon
128
Canadian National Railway
CNI
$76.9B
$30.6M 0.18%
375,727
-6,743
-2% -$536K
KHC icon
129
Kraft Heinz
KHC
$31.3B
$30.2M 0.18%
481,382
-1,174
-0.2% -$69.7K
ADP icon
130
Automatic Data Processing
ADP
$105B
$30.1M 0.18%
224,276
-3,830
-2% -$485K
EW icon
131
Edwards Lifesciences
EW
$50B
$29.7M 0.18%
612,969
-7,785
-1% -$363K
CB icon
132
Chubb
CB
$135B
$29.7M 0.18%
233,577
-3,648
-2% -$485K
AET
133
DELISTED
Aetna Inc
AET
$29.6M 0.17%
161,079
-1,030
-0.6% -$184K
PXD
134
DELISTED
Pioneer Natural Resource Co.
PXD
$29.5M 0.17%
155,821
-2,253
-1% -$432K
SYK icon
135
Stryker
SYK
$133B
$29M 0.17%
171,922
-1,023
-0.6% -$172K
PARA
136
DELISTED
Paramount Global Class B
PARA
$28.7M 0.17%
510,150
+6,283
+1% +$328K
CL icon
137
Colgate-Palmolive
CL
$73.3B
$28.6M 0.17%
441,531
-6,600
-1% -$432K
CME icon
138
CME Group
CME
$96.1B
$27.9M 0.16%
170,412
-36
-0% -$5.88K
DUK icon
139
Duke Energy
DUK
$98.4B
$27.9M 0.16%
353,242
-3,692
-1% -$284K
PLD icon
140
Prologis
PLD
$136B
$27.7M 0.16%
421,418
-8,886
-2% -$571K
HES
141
DELISTED
Hess
HES
$27.6M 0.16%
412,431
-35,889
-8% -$2.14M
ISRG icon
142
Intuitive Surgical
ISRG
$126B
$27.1M 0.16%
169,911
+453
+0.3% +$69.1K
CSX icon
143
CSX Corp
CSX
$93B
$26.9M 0.16%
1,263,054
-39,945
-3% -$823K
SIVB
144
DELISTED
SVB Financial Group
SIVB
$26.5M 0.16%
91,715
+4,508
+5% +$1.32M
WELL icon
145
Welltower
WELL
$170B
$26.4M 0.16%
421,386
-18,694
-4% -$1.04M
EL icon
146
Estee Lauder
EL
$30.7B
$26.4M 0.16%
185,088
+66,104
+56% +$9.78M
CHTR icon
147
Charter Communications
CHTR
$16.9B
$26.1M 0.15%
89,120
-823
-0.9% -$236K
TFCFA
148
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$26M 0.15%
523,686
-7,499
-1% -$296K
WBA
149
DELISTED
Walgreens Boots Alliance
WBA
$25.8M 0.15%
429,730
-6,745
-2% -$434K
PSX icon
150
Phillips 66
PSX
$84.4B
$25.8M 0.15%
229,605
-3,038
-1% -$342K

Similar funds

Aviva's Q2 2018 Portfolio in Review

As of Q2 2018, Aviva held 742 positions worth $16.9B, up 3.6% from $16.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Trading was light in Q2 2018: portfolio turnover was 3.4%. Aviva opened 20 new positions and exited 5, leaving the 742-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Aviva's largest Q2 2018 buy was HDFC Bank: 300,992 shares worth $7.9M.
  • Aviva added most to UnitedHealth in Q2 2018, an estimated $52.6M increase.
  • Aviva's biggest Q2 2018 reduction was Altria Group, cutting an estimated $42.9M.
  • Aviva fully exited VanEck India Growth Leaders ETF in Q2 2018, selling an estimated $57.5M.
  • Aviva's ten largest holdings make up 19% of its $16.9B portfolio in Q2 2018.
  • Aviva opened 20 new positions and closed 5 in Q2 2018.
  • Aviva's portfolio value rose 3.6% quarter-over-quarter to $16.9B.

Based on Aviva's 13F filing for Q2 2018, filed 1 Aug 2018.